Loring Wolcott & Coolidge Fiduciary Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-60	Closed	-$7K	–	773
2020 Q4	$7K	Hold	60	–	–	﹤0.01%	657
2020 Q3	$6K	Hold	60	–	–	﹤0.01%	539
2020 Q2	$7K	Hold	60	–	–	﹤0.01%	525
2020 Q1	$5K	Hold	60	–	–	﹤0.01%	592
2019 Q4	$6K	Hold	60	–	–	﹤0.01%	605
2019 Q3	$7K	Hold	60	–	–	﹤0.01%	595
2019 Q2	$10K	Hold	60	–	–	﹤0.01%	564
2019 Q1	$10K	Hold	60	–	–	﹤0.01%	561
2018 Q4	$6K	Hold	60	–	–	﹤0.01%	595
2018 Q3	$10K	Hold	60	–	–	﹤0.01%	536
2018 Q2	$8K	Hold	60	–	–	﹤0.01%	565
2018 Q1	$7K	Hold	60	–	–	﹤0.01%	608
2017 Q4	$8K	Hold	60	–	–	﹤0.01%	588
2017 Q3	$6K	Hold	60	–	–	﹤0.01%	589
2017 Q2	$7K	Hold	60	–	–	﹤0.01%	564
2017 Q1	$7K	Hold	60	–	–	﹤0.01%	573
2016 Q4	$7K	Hold	60	–	–	﹤0.01%	554
2016 Q3	$8K	Hold	60	–	–	﹤0.01%	559
2016 Q2	$5K	Hold	60	–	–	﹤0.01%	595
2016 Q1	$4K	Buy	+60	New	+$3.29K	﹤0.01%	591

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's GWPH Position: Q1 2021 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 60 shares — an estimated $7K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GWPH in Q1 2016 and held it in 20 quarters. The position peaked at $10K in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 60 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $7K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 20 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $10K in Q2 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2021, filed 14 Apr 2021.